Leanbio is a market oriented CDMO that develops and manufactures biopharmaceutical products as New biological entities and Biosimilars, applying “Lean bioproduction” through tailored quality by design and ICH compliant approach in order to maximize project success, minimize time to market, costs and risks. 

Leanbio follows a knowledge-based strategy, applying cutting edge technological platforms and working altogether with customers through the different stages of development across project lifecycle: 
        
        Platform development
        Specific development
        Process characterization
        Scale-up
        Manufacture

Leanbio covers full value chain of services in the development and manufacture of biotherapeutics from gene to vial.


Biotechnology

Health Care

Pharmaceutical

Therapeutics

Leanbio

Dr. Andreu Soldevila

Albert Font Ingles

Heidi Tveit

Laia Huerga Vallès

Jordi Sarrà Herrera

Leanbio

Org chart

Teams

Offices